)
)
Mark Eccleston
Chief Executive Officer,
ValiRx
Dr Mark Eccleston is CEO of ValiRx Plc, a small cap biotech company listed on London’s AIM market. He's also a director of ValiRx’s subsidiary companies CytoLytix, Inaphaea Biolabs, ValiRx Animal Health and Blue Ribbon Bio. Mark is an entrepreneurial scientist initially trained as a chemist with a focus in drug delivery and holds an MBA. He has founded multiple companies including a diagnostic company listed on the US exchange and took over as CEO of ValiRx in 2024.